Aibin Liang

机构：Tongji University, Tongji Hospital · ORCID：0000-0002-8978-1987

发表论文 229 篇 · 总被引 3412 次 · h-index 29

代表论文

• Benchmarking algorithms for generalizable single-cell perturbation response prediction (2025 · Nature Methods · 被引 22)
• Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study (2025 · 癌症：英文版 · 被引 14)
• A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses (2025 · Nature Communications · 被引 8)
• Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia (2025 · Journal of Hematology & Oncology · 被引 7)
• Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults (2025 · Blood Advances · 被引 5)
• Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma (2025 · Experimental Hematology and Oncology · 被引 3)